NCT03739463 (Pro-MEGA) is a NA clinical trial of MAG-DHA in PPROM, sponsored by Université de Sherbrooke.

Who is sponsoring NCT03739463?

NCT03739463 is sponsored by Université de Sherbrooke.

What drugs are being tested in NCT03739463?

Interventions in NCT03739463: MAG-DHA, Oleic acid.

Is NCT03739463 still recruiting?

NCT03739463 is currently status unknown. Last updated 20 November 2018.

Last reviewed 2018-11-20 · How we verify

NCT03739463: Pro-MEGA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pro-omega-3, Reduction of Inflammation and Modulation of Prematurity

Status unknown NA Last updated 20 November 2018

What this trial tests

NA trial testing MAG-DHA in PPROM in 70 participants. Status unknown.

Timeline

3 December 2018

Primary endpoint
5 November 2019

15 May 2020

Quick facts

Lead sponsor	Université de Sherbrooke
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	other
Enrollment	70
Start date	3 December 2018
Primary completion	5 November 2019
Estimated completion	15 May 2020

Drugs / interventions tested

MAG-DHA
Oleic acid — full drug profile →

Conditions studied

PPROM — all drugs for PPROM →

Sponsor

Université de Sherbrooke — full company profile →

Who can join

Adults 18 to 42, female only, with PPROM. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the project is to decrease the inflammatory status of pregnant women with preterm premature rupture of membranes to delay the initiation of labour that would inevitably lead to premature delivery. The main objective is to measure the mean duration between the initiation of the treatment and delivery in the two groups treated either with MAG-DHA or with the placebo.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for PPROM

Currently open trials in the same condition.

NCT05773014 — Digital vs. Speculum Exams for PPROM · NA · recruiting

Other Université de Sherbrooke trials

Trials by the same sponsor.

NCT07524764 — Female Reproductive Health in Canadian Armed Forces · not yet recruiting
NCT07511842 — REST-Knee: A Pilot RCT of 72-Hour Knee Immobilization and Pain Outcomes · NA · recruiting
NCT07360587 — Thyroid Artery Embolization for the Treatment of Compressive Goiters. · NA · recruiting
NCT07396857 — The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting · NA · recruiting
NCT07122531 — Recovery With Exogenous Ketones and Antipsychotics · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03739463 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Université de Sherbrooke
Last refreshed: 20 November 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03739463.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing